Literature DB >> 7536009

The expression of self antigenic determinants: implications for tolerance and autoimmunity.

M J Mamula1, J Craft.   

Abstract

T lymphocytes respond to small peptides in the context of major histocompatibility molecules and a host of other cell-surface proteins on antigen-presenting cells. By design, therefore, T-cell responses are dependent on the efficient and accurate processing of both foreign and self peptides by antigen-presenting cells. This review examines the functions of T cells that may be specific for self peptides processed and presented under less than ideal conditions or outside the normal pathways of antigen processing. Do these T cells survive selection events and remain in the repertoire of normal lymphocytes? Moreover, can these cells become activated and are they important in the pathogenesis of autoimmunity?

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7536009     DOI: 10.1016/0952-7915(94)90008-6

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  4 in total

Review 1.  Viruses, cytokines, antigens, and autoimmunity.

Authors:  R Gianani; N Sarvetnick
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

2.  Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.

Authors:  Y Zhai; J C Yang; P Spiess; M I Nishimura; W W Overwijk; B Roberts; N P Restifo; S A Rosenberg
Journal:  J Immunother       Date:  1997-01       Impact factor: 4.456

3.  Induction of autoimmunity by immunization with hapten-modified hen egg lysozyme in hen egg lysozyme-transgenic mice.

Authors:  Hee-Kap Kang; Yun Jo Chung; Chung Ung Park; Yong-Suk Jang; Byung S Kim
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

4.  B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

Authors:  D V Serreze; H D Chapman; D S Varnum; M S Hanson; P C Reifsnyder; S D Richard; S A Fleming; E H Leiter; L D Shultz
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.